Intellipharmaceutics International Inc.
IPCIF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $84 | $84 | $772 | $202 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $389 | $389 | $268 | $1,049 |
| Inventory | $0 | $0 | $113 | $113 |
| Other Curr. Assets | $19 | $19 | -$50 | $116 |
| Total Curr. Assets | $493 | $493 | $1,102 | $1,479 |
| Property Plant & Equip (Net) | $940 | $940 | $994 | $1,908 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $2 | $3 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$1 | -$2 | -$3 | -$6 |
| Total NC Assets | $940 | $940 | $994 | $1,908 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,432 | $1,432 | $2,096 | $3,387 |
| Liabilities | – | – | – | – |
| Payables | $3,765 | $3,765 | $3,780 | $4,104 |
| Short-Term Debt | $2,326 | $2,326 | $1,917 | $2,113 |
| Tax Payable | $29 | $29 | $18 | $39 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,124 | $2,124 | $757 | -$658 |
| Total Curr. Liab. | $12,009 | $12,009 | $10,252 | $9,701 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $12,009 | $12,009 | $10,252 | $9,701 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $49,176 | $49,176 | $49,176 | $46,144 |
| Retained Earnings | -$105,134 | -$105,134 | -$102,242 | -$97,097 |
| AOCI | $284 | $284 | $284 | $284 |
| Other Equity | $45,097 | $45,097 | $44,626 | $44,354 |
| Total Equity | -$10,577 | -$10,577 | -$8,155 | -$6,314 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,432 | $1,432 | $2,096 | $3,387 |
| Net Debt | $2,242 | $2,242 | $1,145 | $1,911 |